HomeBiotechnology

Biotechnology Market Research Reports & Consulting

discount on Mnm

Market Reports


Title Published Price TOC Available

Cancer Immunotherapy Market by Type (Monoclonal Antibodies, Cancer Vaccines, Check Point Inhibitors & Immunomodulators), Application (Lung, Breast, Colorectal, Melanoma, Prostate, Head & Neck), End User (Hospital and Clinics) - Global Forecast to 2021

The global cancer immunotherapy market is expected to reach USD 119.39 Billion by 2021 from USD 61.97 Billion in 2016, at a CAGR of 14.0% during the forecast period. Market growth can be attributed to the increasing incidence of cancer, rising demand for therapies with minimal adverse effects, increase in adoption of immunotherapy over other treatment options, and enhanced drug development process. However, stringent regulatory policies and the highly consolidated market which may create an obstacle for the entry of small players are the major factors restraining the growth of this market.

September 2016 $ 5650 selected

Molecular Biology Enzymes and Kits & Reagents Market by Product (Kits & Reagents, Enzymes), Application (PCR, Sequencing, Cloning), End User (Academic & Research Institutes, Hospitals & Diagnostic Centers) - Trends & Global Forecasts to 2021

The molecular biology enzymes and kits & reagents market is projected to reach USD 12.69 Billion by 2021 from USD 5.77 Billion in 2016, growing at a CAGR of 17.1% during the forecast period of 2016 to 2021. Growth in molecular biology enzymes and kits & reagents market can be attributed to the technological advancements in the life science industry, increased research activities in the pharmaceutical and biotechnology sector, rising incidences of infectious diseases and genetic disorders, and successful completion of human genome project.

September 2016 $ 5650 selected

Antibody Production Market by Process (Upstream Processing, Downstream Processing, and Filtration), End-User (Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, and Research Institutes) - Global Forecast to 2021

The antibody production market is projected reach USD 13.28 Billion by 2021 from USD 7.45 Billion in 2016, growing at a CAGR of 12.3% during the forecast period of 2016 to 2021. The antibody production market is segmented on the basis of process and end users. By process, the market is segmented into upstream processing, downstream processing, and filtration.

August 2016 $ 5650 selected

Vaccines Market by Technology (Live Attenuated, Toxoid, Conjugate, Inactivated & Subunit, Recombinant), Disease Indication (Pneumococcal, Influenza, HPV, Hepatitis, Rotavirus, DTP, Polio, MMR), End User (Pediatrics, Adults) & Type - Forecasts to 2021

The global vaccines market is expected to reach 48.03 Billion by 2021 from USD 32.24 Billion in 2016 at a CAGR of 8.3%. The global vaccines market is broadly classified into technology, type, disease indication, end-users, and regions. On the basis of technology, the vaccines market is segmented into conjugate vaccines, inactivated and subunit vaccines, live attenuated vaccines, toxoid vaccines, and recombinant vaccines. The conjugate vaccines segment is expected to account for the largest share of the global vaccines market in 2016. Increasing government support for vaccine development and rising company investments will drive the growth of this market segment.

August 2016 $ 5650 selected

Pyrogen Testing Market by Product (Instruments, Services, Kits and Reagents), Application (Pharmaceutical & Biotechnology, Medical Devices, Other), Test (In Vitro, Lal, Gel Clot, Turbidimetric, Chromogenic, Rabbit) - Global Forecasts to 2021

The global pyrogen testing market is valued at USD 610.2 Million in 2016 and is expected to grow at a CAGR of 12.2%, to reach USD 1086.3 Million by 2021. Pyrogen testing is important and mandatory step in the manufacturing process to remove or inactivate potential bacterial toxins. Pyrogen testing product are used for the treatment and diagnostic purposes in humans. As the disease burden in the world is increasing the demand for the medicines is increasing hence the production of biologicals, injectables etc., is on a rise.

August 2016 $ 5650 selected

Multiplex Assays Market by Product (Consumable (Kits & Reagents, Panels)), Type (Nucleic Acid-Based, Protein-Based), Technology (Pcr, Planar Array), Application (R&D, Companion Diagnostics), End User (Hospital, Clinical Laboratory) - Global Forecast to 2021

The global multiplex assays market is projected to reach USD 3.76 Billion by 2021 from USD 2.66 Billion in 2016, at a CAGR of 7.2% from 2016 to 2021. The multiplex assays market is segmented on the basis of products & service, type, technology, applications, end user, and region. By products & services, the market is categorized into instruments, consumables, accessories, software, and services. The MRI market by type is divided into nucleic acid-based multiplex assays and protein-based multiplex assays. By technology, the multiplex assays market is divides into multiplex polymerase chain reaction, multiplex arrays, and other technologies.

August 2016 $ 5650 selected

Plasma Therapy Market by Type (Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin, Leukocyte-Rich Fibrin), Source (Autologous, Allogenic), Application (Orthopedic, Dermatology, Cardiac Muscle Injury), End User, Region - Global Forecast to 2021

The global plasma therapy market is expected to grow from USD 135.6 Million in 2016 to USD 297.6 Million by 2021, at a CAGR of 14.0% from 2016 to 2021. Factors driving the growth of the plasma therapy market include rising incidences of trauma and increasing healthcare expenditure worldwide.

July 2016 $ 5650 selected

Stem Cell Banking Market by Bank Type (Cord Blood, and Cord Tissue), Service (Collection & Transportation, Analysis, Processing, and Storage), Application (Cerebral Palsy, Leukemia, Thalassemia, Anemia, Autism, Diabetes), Region - Forecast to 2021

The global stem cell banking market is expected to reach USD 3.96 Billion by 2021 from USD 1.58 Billion in 2016, at a CAGR of 20.2% from 2016 to 2021. Increasing awareness regarding storage of cord blood and tissue stem cells, high growth potential of emerging economies, and increasing use of stem cells in the field of therapeutics have opened an array of opportunities for players in the stem cell banking market in the coming years.

July 2016 $ 5650 selected

Animal Genetics Market by Type (Canine, Poultry, Porcine, Bovine), Genetic Material (Semen (Bovine Porcine Equine), Embryo (Bovine Equine)), Testing Services (DNA Testing, DNA Typing, Genetic Disease Testing) - Global Forecast to 2021

The global animal genetics market is projected to reach USD 5.50 Billion by 2021 from USD 3.68 Billion in 2016, at a CAGR of 8.4% from 2016 to 2021. This market is mainly driven by the increasing animal protein consumption, increasing adoption of advanced genetic technologies for larger-scale production and quality breeds, and development of cutting-edge technologies in animal genetic testing. However, stringent regulations regarding animal genetic engineering, expensive and time-consuming R&D activities, high cost of animal testing, and insufficient number of skilled professionals are restraining the growth of the animal genetics market during the forecast period.

July 2016 $ 5650 selected

3D Cell Culture Market by Technology (Scaffold Based, Scaffold Free), Application (Cancer Cell Research, Cell-based Assays/Toxicity Screening), End-Users (Biotechnology & Pharmaceuticals Industries) and Geography- Global Forecast to 2021

The global 3D cell culture market is expected to reach USD 1345.2 Million by 2021 from USD 466.8 Million in 2016, at a CAGR of 23.6%. The global 3D cell culture market is broadly classified by technology, application, end user, and region.

July 2016 $ 5650 selected

Regenerative Medicines Market by Therapy (Cell Therapy, Gene Therapy, Immunotherapy, Tissue Engineering), Product (Cell-Based, Acellular), Application (Orthopaedic & Musculoskeletal Spine, Dermatology, Cardiovascular, Central Nervous System), Region - Global Forecast to 2021

The global regenerative medicines market is expected to reach USD 49.41 Billion by 2021 from USD 17.06 Billion in 2016, at a CAGR of 23.7%. The global regenerative medicines market is broadly classified by product, application, therapy, and region.

July 2016 $ 5650 selected

Vaccine Adjuvants Market by Product Type (Particulate, Emulsions, Pathogen, Saponin), Route of Administration (Subcutaneous, Intramuscular), Disease Type (Infectious, Cancer), Application (Research, Commercial) & Application Category - Forecasts to 2021

The global vaccine adjuvants market is expected to reach USD 769.4 Million by 2021 from USD 467.0 Million in 2016, at a CAGR of 10.5%. The global vaccine adjuvants market is broadly classified into product type, route of administration, disease type, applications, and application categories.

June 2016 $ 5650 selected

Cell Expansion Market by Product (Reagent, Media, Flow Cytometer, Centrifuge, Bioreactor), Cell Type (Human, Animal), Application (Regenerative Medicine & Stem Cell Research, Cancer), End user (Research Institute, Cell Bank) - Global Forecasts to 2021

The global cell expansion market consists of various products used for the mass production of cells. The growth of this market is driven by several factors such as increasing government funding for research, high prevalence of chronic diseases, rising company investments for the development of cell-based products, and growing number of GMP-certified production facilities. The cell expansion market is expected to reach USD 18.76 Billion by 2021 from USD 8.34 Billion in 2016 at a CAGR of 17.6%. This market is segmented based on product, cell type, application, end user, and region.

June 2016 $ 5650 selected

Viral Inactivation Market by Product (Kits, Reagents, Systems, Services), Application (Stem Cell, Blood, Tissue, Cell & Gene Therapy), Method (Solvent Detergent, Pasteurization) & End User (Pharmaceutical and Biotechnology, CROs) - Global Forecast to 2021

The global viral inactivation market is segmented on the basis of method, product, application, end user, and geography. By method, the market is divided into solvent detergent method, pasteurization, and other methods. The global viral inactivation market was valued at USD 320.5 Million in 2016. This market is expected to grow at a CAGR of 12.3% to reach USD 573.0 Million in 2021.

June 2016 $ 5650 selected

In Vitro Toxicology Testing Market by Product, Type (ADME), Toxicity Endpoints & Tests (Carcinogenicity, Dermal Toxicity, Genotoxicity), Technology (Genomics, Transcriptomics), Method (Cellular Assays), Industry (Pharmaceutical) - Global Forecast to 2021

The global in vitro toxicology testing market is expected to USD 27.36 Billion by 2021 from USD 14.15 Billion in 2016, at a CAGR of 14.1% between 2016 and 2021. The major drivers for the market include opposition to animal testing, new & promising technologies, increasing R&D to detect toxicity at early stages and insufficient databases to facilitate the use of in vitro test methods are driving the growth of the global in vitro toxicology testing market. The growing demand for in vitro toxicology testing in the European market will provide new growth opportunities for this market.

June 2016 $ 5650 selected

Animal Growth Promoters & Performance Enhancers Market by Product (Antibiotics, Hormones, Feed Enzymes, Probiotics & Prebiotics, Organic Acids, Phytogenics) & by Animal (Poultry, Porcine, Livestock, Equine, Aquaculture) - Global Forecast to 2020

The animal growth promoters and performance enhancers market is expected to reach USD 9.60 Billion in 2020 from USD 7.56 Billion in 2015, growing at a CAGR of 5%. The global animal growth promoters and performance enhancers market is segmented on the basis of product and animal. By product, the market is categorized into antibiotics, hormonal growth promoters, beta agonist growth promoters, feed enzymes, probiotics and prebiotics, organic acids, phytogenic growth promoters, and others (clay minerals, amino acids, essential oils, and rare earth elements). In 2015, the antibiotics segment accounted for the largest share of the market.

May 2016 $ 5650 selected

Laboratory Filtration Market by Technology (Ultrafiltration, Microfiltration, Nanofiltration, Reverse Osmosis), by Product (Assembly, Filter Paper, Membrane, Syringe Filters, Filtration Microplate, Accessories) & by End User - Global Forecast to 2021

The global laboratory filtration market is projected to reach USD 2.89 Billion in 2021 at a CAGR of 7.2% in the forecast period 2016 to 2021. Rapid technological developments in the laboratory filtration market are positively impacting on the overall growth of the market. The market has witnessed launch of new transforming and innovative technologies in laboratory filtration and filter media products.

April 2016 $ 5650 selected

Single-Cell Analysis Market by Product (Beads, Microplate, Reagents, Flow Cytometer, Microscope, Spectrophotometer), Cell Type (Human, Animal), Technique (NGS, PCR), Application (Cancer, Neurology, NIPD, IVF, CTCs) & End User - Global Forecasts to 2021

The global single-cell analysis market is expected to reach USD 3.35 Billion by 2021 from USD 1.45 Billion in 2016 at a CAGR of 18.2%. The global single-cell analysis market is broadly classified into product, cell type, technique, application, end-users, and regions. On the basis of product, the single-cell analysis market is segmented into consumables and instruments.

April 2016 $ 5650 selected

Digital PCR (dPCR) and qPCR Market by Technology (Quantitative, Digital), Product (Instrument, Reagent, Software), Application (Clinical, Research, Forensic), End User (Hospital, Diagnostic Center, Academia, Pharma-Biotech Co) - Global Forecasts to 2021

The global qPCR and dPCR market is expected to reach USD 4.94 Billion by 2021 from USD 3.28 Billion in 2016, growing at a CAGR of 8.5% from 2016 to 2021. Market growth can be attributed to the rising incidences of infectious diseases and genetic disorders (coupled with growing geriatric population that is at greater risk of target diseases as compared to adults); technological advancements; increasing public-private investments, funds, and grants; successful completion of the Human Genome Project, and rise in the number of hospitals and diagnostic centers. However, high device costs associated with dPCR devices and technical limitations associated with qPCR and dPCR products are major factors restraining the market growth during the forecast period.

April 2016 $ 5650 selected

Cell Lysis/Cell Fractionation Market by Product (Consumables (Reagents, Enzymes, Detergent), Instruments (Sonicator, Homogenizer)), Type of Cell (Microbial, Mammalian), End User (Research Laboratories, Biopharmaceutical & Biotechnology Companies) - Global Forecasts to 2021

The global cell lysis market is expected to reach USD 3.84 Billion by 2021 from USD 2.35 Billion in 2016 at a CAGR of 10.3% from 2016 to 2021. The major factor driving the growth of this market are increasing government funding for research, high prevalence of diseases, expanding biotechnology and biopharmaceutical industries, and growing focus on personalized medicine

April 2016 $ 5650 selected

Sterile Filtration Market by Product (Membrane Filters, Cartridges & Capsules, Syringe Filters), Application (Bioprocesses, Fill-finish process, Utilities Filtration, Pre-Filtration), Membrane Pore Size (0.22 Microns), End-User - Global Forecast to 2020

The global sterile filtration market is expected to USD 7.46 Billion by 2020 from USD 4.00 Billion in 2015, at a CAGR of 12.4% between 2015 and 2020. Filtration is an important operation in the pharmaceutical industry, as it not only ensures that the products are adequately purified and fit for consumption, but also helps to optimize process economics and prevent loss of valuable product.

April 2016 $ 5650 selected

Analytical Standards Market by Technique (Chromatography, Spectroscopy, Titrimetry, Physical Property Testing), Application (Food & Beverage, Environmental, Pharmaceutical, Cosmetic, Veterinary, Forensics, Petrochemistry) - Global Forecast to 2020

The global analytical standards market is expected to be valued at USD 1.14 Billion in 2015, growing at a CAGR of 6.5% during the forecast period to reach USD 1.56 Billion in 2020. This market is mainly driven by factors such as rising demand for analytical instruments in proteomics & metabolomics and growing importance of analytical tests in drug approval. On the other hand, high cost of analytical instruments & standards is restricting the growth of the global analytical standards market.

April 2016 $ 5650 selected

Virus Filtration Market by Product (Kits & Reagents, Systems, Services), Application (Biologics (Vaccine & Therapeutics, Blood, Tissues, Stem Cells), Devices, Air, Water Purification), End User (Biopharmaceutical, CROs, Research) - Global Forecast to 2020

The global virus filtration market is projected to reach USD 3.25 Billion by 2020 from USD 1.82 Billion in 2015, at a CAGR of 12.3% between 2015 and 2020. Virus filtration is an important operation in the pharmaceutical industry, as it not only ensures if the products are adequately purified and fit for consumption, but also helps to optimize process economics and prevent loss of valuable product.

April 2016 $ 5650 selected

Viral Clearance Market by Application (Stem Cell, Blood, Tissue, Cell & Gene Therapy), Method (Inactivation, Removal (Precipitation), Detection (PCR, ELISA)) & End User (Pharmaceutical & Biotechnology, CROs, Research Institute) - Global Forecast to 2020

The global viral clearance market was valued at USD 285.5 Million in 2015 and poised to grow at a CAGR of 12.3% between 2015 and 2020, to reach USD 510.3 Million in 2020. Viral clearance study is carried out by manufacturers to detect virus contaminations in biologics and other products. Viral clearance testing is necessary by regulatory authorities for investigational new drug (IND) submission and is mainly critical in process development for biologicals including tissue and tissue products, stem cell products, cellular and gene therapy products, blood and blood products, and vaccine and therapeutics.

April 2016 $ 5650 selected

Terahertz and Infrared Spectroscopy Market by Spectrum (Near/Mid /Far-Infrared), by Technology (Benchtop/Portable & Handheld), by Application (Semiconductors/Homeland Security/Pharmaceutical & Biotechnology/Industrial Chemistry) - Global Forecasts to 2020

The terahertz spectroscopy market is expected to reach USD 52.53 Million in 2020 from USD 20.0 Million in 2015 at a CAGR of 21.30%. The market is dominated by North America, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). Asia-Pacific is expected to grow at the fastest rate during the forecast period.

March 2016 $ 5650 selected

Next-Generation Sequencing (NGS) Market by Platforms (HiSeq, MiSeq, HiSeq X Ten/X Five, Nextseq500, Ion Proton, PGM, IonS5, PacBio & Sequel), Services (Targeted Sequencing, De novo), & Application (Diagnostic, Drug Discovery) - Global Forecasts to 2021

The NGS market is expected to reach USD 10,371.1 Million by 2021 from USD 4,031.7 Million in 2016, at a CAGR of 20.8% between 2016 and 2021. Technological advancements in NGS products, increasing applications of NGS, entry of new market players, and increasing partnerships & collaborations among market players majorly drives the growth of the NGS market. Other growth factors include growing incidences of cancer, inherited rare disorders, and pre- and neo-natal disorders.

March 2016 $ 5650 selected

North American Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET- F-18), Therapeutic (Beta Emitters – I-131, Alpha Emitters, Brachytherapy – Y-90)), by Application (Oncology, Cardiology) - Forecasts to 2020

The North American nuclear medicine/radiopharmaceuticals market is poised to reach USD 2.98 Billion by 2020, growing at a CAGR of 8.6% during the forecast period of 2015 to 2020. The growth of the overall North American nuclear medicine/radiopharmaceuticals market can be contributed to increasing preference for SPECT and PET scans, alpha radioimmunotherapy-based targeted cancer treatment, advances in radiotracers, growing incidence of cancer and CVDs, and rising awareness about the effective use of radiopharmaceuticals.

March 2016 $ 5650 selected

Genomics Market by Product (Instruments, Consumables), Technology (Sequencing, PCR, Microarray), Application (Diagnostics, Personalized Medicine), Process (Library Preparation, Sequencing & Imaging), End User - Trends & Global Forecasts to 2020

The genomics market is poised to reach USD 19.99 Billion by 2020, growing at a CAGR of 9.9% during the forecast period of 2015 to 2020. The growth of the overall genomics market can be contributed to increasing investments, grants, and funds by the government; increasing research in the field of genomics; increasing number of start-up companies; and increasing application of genomic sequencing in the diagnostics. However, the high cost of genomic sequencing instruments/systems is likely to restrain the growth of the market during the forecast period.

February 2016 $ 5650 selected

Business Model Analysis in Antimicrobial Coatings for Medical Devices Key Players (Specialty Coatings Systems, Inc. (SCS), Royal DSM, Hydromer, Inc., PPG Industries, Inc., and BASF SE)

Medical devices are made of metals, such as stainless steel, aluminum, and ceramic. Many of these materials are not compatible with body tissues and fluids and can cause complications such as infections and blood clots. According to the Centers for Disease Control and Prevention (CDC), around 2,000,000 patients contract hospital-acquired infections (HAIs) every year in the U.S., resulting in 100,000 deaths; HAIs cost the U.S. healthcare system an estimated USD 45 billion annually. In addition, according to the European Centre for Disease, around 4,131,000 patients suffer from healthcare-associated infections every year in Europe. Rise in incidence of HAIs is a major challenge for healthcare providers; therefore, antimicrobial coatings have gained importance in recent years.

February 2016 $ 5650 selected

Cell Culture Market by Equipment (Bioreactor, Culture Vessels (Multiwell Plates, Petri Dish)), Consumables (FBS, ABS, Media, Reagents), Application (Therapeutics, Stem Cell), End Users (Pharmaceutical and Biotechnology, Research) - Forecast to 2020

The cell culture market is projected to reach USD 18,630.7 Million by 2020 from USD 11,310.9 Million in 2015. Major factors driving the growth of this market include increasing incidence of chronic diseases, increasing regulatory approvals for cell culture-based vaccines, growing demand for monoclonal antibodies (mAbs), funding for cell-based research, growing use of single-use technologies, and technological advancements in cell culture products. On the other hand, factors such as high cost of research in cell biology, and lack of infrastructure for cell-based research are likely to hinder the market growth.

February 2016 $ 5650 selected

Knock out Mouse Model- Pricing Analysis, [by Indication, Mouse type, End users, Discounting, Corporate Agreements, Economic Model of Demand and Supply, Physiological Characteristics, Business Models, and Stakeholder Analysis]

Mice models are indispensable tools in research activities with their capability to elucidate human disease processes, due to striking similarities between the anatomy, physiology, and genetics of humans and mice. These advantages promote scientific discovery, understanding of the functions of individual genes, mechanisms of different diseases, and the effectiveness and toxicities of various drug molecules. Mice models are the most popularly used animal models due to their small size, short generation time, accelerated lifespan, low cost, and requirement of less space. These factors help in accelerating the research and development of drug therapies.

February 2016 $ 5650 selected

Electrophoresis Reagents Market by Product (Dyes (EtBr & SYBR) Gels (Polyacrylamide, Starch, & Agarose) Buffer (TBE & TAE)) by Application (Protein Analysis, DNA & RNA Analysis) by Technique (Gel & Capillary Electrophoresis) - Global Forecast to 2020

The global electrophoresis reagents market is projected to reach USD 1.05 Billion by 2020, at a CAGR of 5.4% from 2015 to 2020. The electrophoresis reagents market witnessed substantial growth and rapid technological advancements in the past few years, which had a positive impact on the overall growth of the market. The advancements have allowed the electrophoresis technique to be used in many new applications.

February 2016 $ 5650 selected

Pharmaceutical Filtration Market by Product (Membrane Filters, Single-use systems), Techniques (Ultrafiltration, Cross Flow Filtration), Applications, Scale of Operations, Geography (North America, Europe) - Global Forecast to 2020

The global pharmaceutical filtration market is expected to reach USD 20,190.1 Million by 2020 from USD 12,451.3 Million in 2015, at a CAGR of 10.2% between 2015 and 2020. Filtration is an important operation in the pharmaceutical industry, as it not only ensures if the products are adequately purified and fit for consumption, but also helps to optimize process economics and prevent loss of valuable product. Growth of biopharmaceutical industry, advancements in nanofiber technology, rapid expansion in generic drug production, increasing incidences of airborne disease, and strong biologics product pipeline are driving factors of the pharmaceutical filtration market.

February 2016 $ 5650 selected

Epigenetics Market by Product (Modifying Enzymes, DNA Polymerase, Acetylase, Methyltransferase, Instruments & Consumables, Kit, Bisulphite Conversion Kit, Reagents), by Research Area (Developmental Biology, Oncology) - Global Forecast to 2020

The epigenetics market is expected to reach USD 890.0 Million by 2020 from USD 469.6 Million in 2015, at a CAGR of 13.64% between 2015 and 2020. Increasing research activities by academic and research institutes and high prevalence of cancer will majorly drive the growth of the epigenetics market. Other growth factors include the increasing application for non-oncology diseases; and growing partnership between academic, biotechnology and pharmaceutical companies. The new emerging markets such as Brazil, Russia, India and China will provide opportunities for market growth.

February 2016 $ 5650 selected

Label-Free Detection Market by Technology (Surface Plasmon Resonance, Bio-Layer Interferometry), Products (Consumables, Microplates, Biosensor Chips), Applications (Binding Kinetics, Binding Thermodynamics, Lead Generation) - Global Forecasts to 2020

The global label free detection market is valued at USD 1.22 Billion in 2015 and expected to reach USD 2.13 Billion by 2020, at a CAGR of 11.86% from 2015 to 2020. Label-free technologies are increasingly used in drug discovery for the detection and characterization of molecular interactions. The inherent advantages of label-free technology over alternative technologies like ELISA and flow cytometry are a significant factor driving its adoption.

January 2016 $ 5650 selected

Gene Expression Analysis Market by Technology (DNA Microarray, PCR, NGS, SAGE, Northern Blotting), Consumables (DNA Chips, Reagents), Services (Gene Profiling, Bioinformatics) & Applications (Research, Drug Discovery, Diagnostic) - Global Forecasts to 2020

The global gene expression analysis market is projected to reach USD 5.30 Billion by 2020 from USD 3.39 Billion in 2015, at a CAGR of 9.3% from 2015 to 2020. Factors such as availability of funding, growing number of cancer patients, strong focus on research, and decreasing cost of sequencing are driving growth in this market. The increasing focus on precision medicine initiative worldwide is expected to provide growth opportunities for the market. North America dominates the global gene expression analysis market in 2015.

January 2016 $ 5650 selected

Surgical Sutures Market by Type (Automated Suturing Devices, Absorbable and Non-Absorbable Sutures), Application (General, Cardiovascular, Valve, Orthopedic, Dental, Ophthalmic), and Geography - Global Forecast to 2020

The global sutures market was valued at USD 2.80 Billion in 2014 and is expected to reach USD 3.59 Billion by 2020, at a CAGR of 4.2% from 2015 to 2020. The expansion of the wound care management sector is among the major factors driving the demand for sutures in the market. Another major factor contributing to the growth of this market is technological innovation, such as absorbable sutures with precise control of absorption rates that provide optimal conditions for tissue healing. It is predicted that a series of new products will be launched, which will incorporate improvements to suture degradation characteristics and provide increased product flexibility.

January 2016 $ 5650 selected

Mice Model Market by Type (Inbred, Knockout, Hybrid), Technology (Microinjection, Embryonic stem Cell), Disease (Oncology, Diabetes), Service (Breeding, Quarantine, Genetic testing) & Care Products (Bedding, Feed) - Analysis & Global Forecast to 2020

The mice model market is projected to reach USD 1.49 Billion by 2020 from USD 1.05 Billion in 2015, at a CAGR of 7.1% in the next five years (2015 to 2020). The growth of the overall mice models market can be contributed to ongoing innovations in mice models, continuous support in the form of investments and grants, and personalized medicine fueling the demand for personalized humanized mice models are some of the factors driving the growth of the mice model market.

January 2016 $ 5650 selected

qPCR Reagents Market by Detection (Dye-based, Probe-based), Packaging (qPCR Core Kits, Master Mixes), End User (Hospitals, Diagnostic Centers, Academia, Research Labs, CRO), Application (Diagnostic, Research, Forensic) - Global Forecasts to 2020

The Global qPCR reagents market is poised to reach ~USD 1,893.9 Million by 2020 From USD 1,307.0 Million in 2015, growing at a CAGR of 7.7%, during 2015 to 2020. Market growth can be attributed to factors such as rising patient population base for infectious diseases & genetic disorders, coupled with growing geriatric population, technological advancements in the life sciences sector, increasing public-private investments, funds, and grants for PCR-based research, and the successful completion of the human genome project. However, technical limitations associated with qPCR are restraining the growth of this market.

January 2016 $ 5650 selected

Cell Analysis Market by Product (Instrument (PCR, HCS, Spectrophotometer, Microscope), & Consumables (Assay, Reagent)), by Process (Cell Proliferation, Single Cell Analysis), & by End User (Hospital, Pharmaceutical, Biotechnology, CRO) - Forecast to 2020

The global cell analysis market is expected to reach USD 26.0 Billion by 2020 from USD19.0 Billion in 2015, growing at a CAGR of 6.56% from 2015 to 2020. Major factors driving growth of this market include increasing Corporate and government funding for cell-based research rising incidence of chronic and infectious diseases, growing healthcare industry and medical spending, rising incidence of cancer, and introduction of technologically advanced products are likely to propel the growth of this market. However, high cost of cell analysis systems, complex and time-consuming regulatory guidelines lengthen the approval process, and intellectual property rights issues restrict innovations in assay kits.

January 2016 $ 5650 selected

Human Microbiome Market by Indication (Obesity, Cancer), Application (Therapeutic, Diagnostic), Product (Prebiotics, Food, Drugs), Product Research (Instruments, Consumables), Technology Research (High Throughput, Omics Technology) - Global Forecast to 2023

The human microbiome market is expected to reach USD 658 Million by 2023 from USD 294 Million in 2019 growing at a CAGR of 22.3% during the forecast period (2019–2023). The market is driven by growing incidences of unhealthy lifestyle diseases, and increase in occurrence of autoimmune disorders. However, government regulation and lack of detailed research may restrain the growth of this market to an extent. Investing in probiotic and prebiotic products, medical foods, drugs, and devices will prove fruitful for companies in the future.

January 2016 $ 5650 selected

Cell Isolation/Cell Separation Market by Product (Reagent, Media, Serum, Bead, Centrifuge), Cell Type (Human, Stem Cell, Animal), Technique (Filtration, Surface Marker), Application (Research, IVD) & End user (Hospital, Biotechnology) - Forecast to 2020

The global cell isolation market is expected to reach USD 6.3 Billion by 2020 from USD 2.9 Billion in 2015, growing at a CAGR of 16.8% from 2015 to 2020. The cell isolation market is segmented on the basis of product, cell type, technique, application, end user, and geography.The global cell isolation market involves various products that help in separating specific cells from a tissue or a sample. This market is driven by several factors which include increasing usage of cell isolation in cancer research, increasing number of biotechnology and biopharmaceutical industries, technological advancements, high prevalence of infectious diseases, rising aging population, and growth in government investments.

December 2015 $ 5650 selected

Human Insulin Market - Drugs (Biologics, Biosimilars), Type (Short Acting, Long Acting, Premixed), Brands (Lantus, NovoRapid, Humalog), Delivery Devices (Pens, Pen Needles, Syringes), Applications (Type 1 Diabetes, Type 2 Diabetes) - Forecasts to 2020

The global human insulin market is poised to reach ~USD 39.13 Billion by 2020 growing at a CAGR of 8.1% from 2015 to 2020. Market growth can be attributed to factors such as growing diabetes patient population, increasing population exposure to key risk factors leading to diabetes, rising market demand for human insulin analogs, technological advancements in the field of human insulin delivery devices, and favorable medical reimbursements. However, stringent regulatory requirements for product approval are restraining the growth of human insulin market.

December 2015 $ 5650 selected

Biomaterials Market by Type of Material (Metallic, Ceramic, Polymers, Natural Biomaterials) & Application (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Neurology, Tissue Engineering, Ophthalmology) - Global Forecast to 2020

The biomaterials market is poised to reach USD 130.57 Billion by 2020, growing at a CAGR of 16% during the forecast period of 2015 to 2020. The growth of the overall biomaterials market can be contributed to increased funds & grants by government bodies worldwide, growing implantable devices market, technological advancements, rising number of hip and knee replacement procedures, and high growth in geriatric population coupled with growing incidence of cardiovascular diseases.

December 2015 $ 5650 selected

Protein Labeling Market by Product (Reagents, Kits, & Services), Labeling Method (In Vitro Labeling, In Vivo Labeling), Application (Cell-Based Assay, Fluorescence Microscopy, Immunological Technique), & Region - Global Forecast to 2020

The protein labeling market is expected to reach USD 1,894.5 Million by 2020 from USD 1,089.5 Million in 2015, at a CAGR of 11.7%. Protein labeling is carried out using labeling reagents and kits to label an antibody or other protein, to make a fluorescent probe, enzyme conjugate, biotinylated binding reagent, or iodine-labeled tracer for detecting proteins in tissues, cells, and biochemical assays.

December 2015 $ 5650 selected

Nucleic Acid Labeling Market by Product (Reagents & Kits, Services), Applications, Labeling Techniques (PCR, Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription, End Labeling), by Region - Global Forecast to 2020

The global nucleic acid labeling market is expected to USD 1,925.7 Million by 2020 from USD 1271.8 Million in 2015, at a CAGR of 8.65% between 2015 and 2020. Nucleic acid can be labeled using several different methods including incorporation of fluorescent tags, biotin, and enzymes. The labeled nucleic acid can be used for a variety of applications, including DNA sequencing, PCR, FISH, microarrays, blotting, and in situ hybridization. This market report studies the potential of reagents & kits and services for various applications by using PCR, nick translation, random primer labeling techniques.

December 2015 $ 5650 selected

Oligonucleotide Synthesis Market by Product & Services (Primer, Probe, Custom Oligos, Reagent, Equipment), Application (PCR, Gene Synthesis, Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical & Biotech, Diagnostic Labs) - Global Forecast to 2020

The oligonucleotide synthesis market is expected to reach USD 1,918.6 Million by 2020 from USD 1,078.1 Million in 2015. Major factors driving the growth of this market include increasing R&D expenses in pharmaceutical and biotechnology companies, rising demand for synthesized oligonucleotides due to the growing field of molecular diagnostics, increasing government investments to develop genomic technologies, rising venture capital investments, and increasing demand for synthetic genes.

November 2015 $ 5650 selected

Nucleic Acid Isolation and Purification Market by Product (Reagents, Kits, Instruments), Technology (Column-, Reagent-, Magnetic Bead-based), Application (Plasmid, Genomic DNA, miRNA, Total RNA, PCR Clean-up), & End Users - Global Forecast to 2020

The global nucleic acid isolation and purification market is expected to reach USD 3,837.42 million by 2020 from USD 2,560.31 million in 2015, growing at a CAGR of 8.43% between 2015 and 2020. Nucleic acid isolation and purification is a set of molecular biology techniques used for the extraction of DNA and RNA for use in downstream applications. The scope of this market report is to cover various reagents, kits, and instruments used for the isolation and purification of DNA, RNA, and modified nucleic acids.

November 2015 $ 5650 selected

Cell-based Assays Market by Product (Cell Lines, Reagents, Kits, Instruments, Software, Services), Applications (Research, Drug Discovery, ADME Studies, Toxicology), End User (Pharmaceutical Companies, Academics, CRO), & Region - Global Forecast to 2020

The global cell-based assays market is expected to reach USD 18,329.37 Million by 2020 from USD 10,799.53 Million in 2015, growing at a CAGR of 11.16% between 2015 and 2020. Cell-based assays market refers to a wide range of sensitive and reliable methods for research studies on live cells for basic research-based and commercial applications used in pharmaceutical & biotechnology companies, academic & government institutions and contract research organizations. Increasing R&D spending and advancements in cell-based assay techniques will drive the growth of the cell-based assays market.

November 2015 $ 5650 selected

European NGS Services Market by Technology (SBS, SBL, SMRT, Pyrosequencing), Application (Exome Sequencing, CHIP-Seq), End User (Pharmaceutical Companies, Hospital), Disease [Oncology (Prostate, Lung, & Breast Cancer), Rare Diseases) - Forecast to 2020

The NGS services market in Europe is expected to reach USD 1,152 Million by 2020 from USD 444 Million in 2015, at a CAGR of 21% from 2015 to 2020. Factors such as rising preference of NGS over other platforms; rapid and cost-efficient sequencing; rising prevalence of inherited diseases; application of genomics in drug discovery; growing prevalence of cancer and other malignant diseases; and partnerships among companies, R&D centers, and universities are expected to drive market growth. However, high dependence on grants for R&D, lack of analytics, and stringent reimbursement policies are likely to restrict the growth of this market to a certain extent.

October 2015 $ 5650 selected

EDS, WDS, EBSD, Micro-XRF Instruments Market by Product, by Application (Energy, Defense, Metals, Medical, Research, Agriculture, Nanotechnology, Electronics, Biotechnology, Automotive, Pharmaceutical, Oil and Gas) - Global Forecasts to 2019

The global EDS, WDS, EBSD, and Micro-XRF instruments market is segmented on the basis of products, applications, and regions. Based on products, the market is categorized into EDS, WDS, EBSD, and Micro-XRF. The EDS segment accounted for a major share of the market, by product, in 2014. The global EDS, WDS, EBSD, and Micro-XRF instruments market is expected to reach USD 1,529.6 Million by 2019 from USD 403.6 Million in 2014, at a CAGR of 5.6% during the forecast period.

October 2015 $ 5650 selected

Cancer Biomarkers Market by Tumor (Breast, Lung, Prostate), Type (Protein & Genetic Biomarkers), Profiling Technology (Proteomics, Genomics, Imaging, Immunoassay), Application (Diagnostic, Drug Discovery, Prognostic) & Geography - Global Forecast to 2020

The global cancer biomarkers market has experienced substantial growth over the last couple of years. This market is expected to grow at a CAGR of 11.6% from 2015 to 2020. Factors such as rising incidence of cancer; technological advancements in omics technologies; favorable government funding for cancer research; increased demand for personalized medicines in cancer therapies; and increased use of biomarkers in drug discovery development and clinical trials are expected to fuel the growth of the cancer biomarkers market during the forecast period. The global cancer biomarkers market is expected to reach USD 15,973.8 Million by 2020, at a CAGR of 11.6% from 2015 to 2020.

August 2015 $ 5650 selected

Biopreservation Market by Product (Media, Sera, Cryogenic Storage Systems, Thawing Equipment, Alarms), Biospecimen (Human Tissue, Stem Cells, Organs), Application (Therapeutic, Regenerative Medicine, Clinical Trials), End User - Global Forecast to 2020

The global biopreservation market is expected to reach USD 3,731.03 Million by 2020 from USD 2,150.48 Million in 2015, growing at a CAGR of 11.65% between 2015 and 2020. Biopreservation ensures the stability, quality and purity of biospecimens preserved in biobanks, hospitals, and gene banks. Increasing healthcare expenditures and demand for preserving new-born’s stem cells will drive the growth of the biopreservation market. The applications included in this report are therapeutic applications, research applications, clinical trials and other applications. The therapeutic applications had the largest share of the biopreservation media & equipment market in 2015. Therapeutics is expected to one of the fastest growing applications between 2015 and 2020.

August 2015 $ 5650 selected

Rat Model Market by Type (Outbred, Knockout, Conditioned), Technology (Microinjection, Embryonic Stem Cells), Application (Toxicology, Oncology, CNS), Service (Breeding, Cryopreservation, Quarantine) & Care Products (Cages, Bedding, Feed) - Forecasts to 2020

Rat models are increasingly being used in pharmaceutical and biotechnology industries for research activities due to the capability of rats to elucidate human disease processes. In addition, there is a striking similarity between the anatomy, physiology, and genetics of humans and rats. Advanced technologies such as CRISPR/Cas 9 and Zinc Finger Nucleases have enabled the generation of economically and technically feasible transgenic rat models, owing to which the rat model market is likely to grow at a higher CAGR than markets for other animal models. This report studies the global rat model market over the forecast period of 2015 to 2020. The market is estimated at USD 358.5 Million in 2014 and is expected to reach USD 602.3 Million by 2020, growing at a CAGR of 9.4% from 2015 to 2020.

August 2015 $ 5650 selected

In-Situ Hybridization Market by Type( DNA,RNA), Application (Cancer Diagnosis, Cytology, Immunology), End User (Hospitals, Pharma & Biotech, Research Labs) & by Geography - Analysis and Forecast to 2019

In-situ hybridization has applications across varied industry verticals, such as cancer diagnostics, immunology, neurosciences, and cytology. Cancer diagnostics is anticipated to be the leading application segment of the in-situ hybridization market. The global in-situ hybridization market is estimated at $554.4 Million 2014 and is projected to reach $681.0 Million by 2019, at a CAGR of 4.2% from 2014 to 2019.

August 2015 $ 5650 selected

Laser Capture Microdissection Market by Product (Consumables, Instruments, Software, Services), System Types (Ultraviolet, Infrared, Immunofluorescence), Application (Molecular Biology, Cell Biology, Forensics), End User - Global Forecast to 2020

The global laser capture microdissection market is expected to reach USD 124.97 Million by 2020 from USD 72.45 Million in 2015, at a CAGR of 11.52% between 2015 and 2020. Laser capture microdissection (LCM) is a contact- and contamination-free method of isolating specific single cells or entire areas of tissues from a wide variety of samples using a focused laser beam. This technique preserves the original morphology of the dissected tissue sample. This market report studies the potential of instruments, consumables, and software for diagnostics and research and development in the molecular analysis of tissue samples.

August 2015 $ 5650 selected

Platelet Aggregation Devices Market by Product (Systems, Reagents, Consumables, Accessories), Application (Research, Diagnostic, CVD, Orthopedic, Trauma), End User (Hospitals, Diagnostic Laboratories, Academia, Blood Banks) - Global Forecasts to 2020

The global platelet aggregation devices market is poised to reach a value of 342.4 Million by 2020, growing at a CAGR of 21.0% from 2015 to 2020. Factors such as rising incidences of target diseases, rapid growth in the geriatric population across the globe, technological advancements in platelet aggregometers, and increasing number of industry-academia collaborations and clinical studies are fueling the growth of the global platelet aggregation devices market. However, procedural limitations, unfavorable healthcare reforms in the U.S., and dearth of well trained and skilled professionals are some of the key factors restraining the growth of this market.

August 2015 $ 5650 selected

European Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Hormonal, Oncology), Usage Pattern (Curative Care, Immunization), Administration (Skin, Musculoskeletal), End User (Hospital, Home care Setting) - Forecast to 2020

The European injectable drug delivery market is expected to reach $207.3 Billion by 2020 from $114.7 Billion in 2015, growing at a CAGR of 12.6% from 2015 to 2020. Factors such as rising prevalence of chronic diseases, growth of the biologics market, demand of self-injection devices, and technological advancements are driving the growth of this market. On the other hand, alternative delivery methods such as oral and transdermal, safety concerns, and blood-borne infections are hindering the growth of this market.

July 2015 $ 5650 selected

Biomarkers Market by Product (Consumables, Services), Type (Predictive, Pharmacodynamic, Safety), Application (Diagnostics, Drug Discovery, Personalized Medicine) & by Disease Indication (Cardiovascular, Immunological) - Global Forecast to 2020

The global biomarkers market is expected to reach $45.55 Billion by 2020 from $24.10 Billion in 2015, at a CAGR of 13.58% between 2015 and 2020. Increasing healthcare expenditure & R&D spending and the increasing utility of biomarkers for diagnostics are expected to drive the market. Market growth will also be aided by the low cost of clinical trials in developing countries and new initiatives undertaken for biomarker research. On the other hand, the need for high capital investment, low benefit-cost ratio, poorly suited regulatory & reimbursement systems, and the high cost of tests and sample collection & storage are the major factors restraining the growth of this market.

July 2015 $ 5650 selected

Biosimilars Market by Product (Recombinant Non-Glycosylated Proteins (Insulin, Filgrastim, Interferons, rHGH), Glycosylated (Monoclonal Antibodies, EPO), Peptides (Glucagon, Calcitonin)) & Application (Oncology, Blood Disorders) - Global Forecast to 2020

The global biosimilars market is expected to reach $6.22 Billion by 2020 from $2.29 Billion in 2015, growing at a CAGR of 22.1% from 2015 to 2020. The growth of the global biosimilars market is driven by factors such as growing pressure to curtail healthcare expenditure, growing demand for biosimilar drugs due to their cost-effectiveness, rising incidences of various diseases, increasing number of off-patented drugs, positive outcome in the ongoing clinical trials, and rising demand for biosimilars in different therapeutic applications such as rheumatoid arthritis and blood disorders. However, factors such as high manufacturing complexities and costs, stringent regulatory requirements in countries, and innovative strategies by biologic drug manufacturers to restrict the entry of new players are restraining the growth of this market.

July 2015 $ 5650 selected

Neuromodulation Market by Technology (Deep Brain Stimulation, Spinal Cord Stimulation, Transcranial Magnetic Stimulation) & by Application (Depression, Parkinson’s, Tinnitus, Alzheimer’s, Epilepsy, Ischemia, Obesity) - Trends & Global Forecast to 2020

The neuromodulation market is segmented on the basis of technology, application, and region. The global neuromodulation market is expected to grow at a CAGR of 11.2% from 2015 to 2020, to reach $6.20 Billion by 2020 from $3.65 Billion in 2015. Factors such as rising geriatric population, increasing prevalence of neurological diseases, strong product pipeline offered by the players, and expanded target applications and new indications are driving the growth of this market. Moreover, expansion in emerging economies is likely to create significant growth opportunities for players operating in the neuromodulation market. However, factors such as unfavorable reimbursement scenario and lack of trained professionals act as restraints hindering its market growth.

July 2015 $ 5650 selected

Transfection Reagents and Equipment Market by Method (Biochemical (Calcium Phosphate, Lipofection, Dendrimers), Physical (Electroporation, Nucleofection), Viral) & by Application (Biomedical, Protein Production) - Analysis & Global Forecast to 2020

The transfection reagents and equipment market is segmented on the basis of product, method, application, and region. Increase in biomedical and cell-based research, technological advancements in transfection equipment and reagents, and rise in incidence of cancer worldwide are major factors driving the growth of this market. The transfection reagents and equipment market is expected to reach $957.9 Million by 2020 from $676.8 Million in 2015, growing at a CAGR of 7.2% from 2015 to 2020.

June 2015 $ 5650 selected

Aptamers Market by Type (DNA, RNA, XNA), Application (Diagnostics, Therapeutics, R&D), Technology (SELEX, Other Technologies) & by End Users (Academic Research Institutes, Biotechnology & Pharmaceutical Companies, CRO) - Global Forecast to 2020

The global aptamers market is expected to reach $244.93 Million by 2020 from $107.56 Million in 2015, at a CAGR of 17.89%. Aptamers bind to target protein, lipid, or nucleic acid molecules with a high degree of specificity. Aptamers can be generated rapidly and applied in the specific detection, inhibition, and characterization of proteins. These can be used as pharmaceutical leads, detection reagents, and functional proteomic levels (with small molecules, antibodies, or other aptamers). The scope of this market report includes DNA-, RNA-, and XNA-based aptamers used for research applications.

June 2015 $ 5650 selected

Expression Vectors Market by Host Type (Bacterial/E.Coli, Mammalian/CHO, Insect/Baculovirus, and Yeast), Application (Therapeutic, Research, and Industrial), End User (Pharmaceutical, Biotechnology, CROs & CMOs, and Academic Research) - Forecast to 2020

The expression vectors market is expected to reach $317.1 Million by 2020 from $242.7 Million in 2015, growing at a CAGR of 5.5% from 2015 to 2020. Major factors driving the growth of this market include the increasing demand of protein-based drugs (biologics); high prevalence of lifestyle diseases, infectious diseases, and genetic disorders; and increasing funding for protein research. On the other hand, high market consolidation, which increases entry barriers, and high cost of protein therapy are the major factors restraining the growth of this market.

June 2015 $ 5650 selected

Medical Aesthetics Market by Products (Liposuction, Cellulite Reduction, Fat Reduction, Skin Tightening, Breast Implants, Botox, Dermal Fillers), Procedures (Cosmetic & Reconstructive), & End-Users (Beauty center and Home) - Global Forecast to 2020

The global medical aesthetics market is estimated to grow at a CAGR of 10.8% in the forecast period. The increasing demand of minimally invasive and non-invasive aesthetic procedures, technological advancements in energy based devices, and rapid growth in number of cosmetic procedures are the key factors fuelling the growth of the medical aesthetics market. This report studies the global medical aesthetics market over the forecast period of 2015 to 2020. The market is expected to reach ~$12,581.9 Million by 2020, at a CAGR of 10.8% from 2015 to 2020.

June 2015 $ 5650 selected

Electrophoresis Market by Product (1D & 2D Gel Electrophoresis, Agarose & Polyacrylamide Gel, Capillary Electrophoresis, Isoelectric Focusing, Isotachophoresis, CZE, CGE, MEKC, Reagents, Informatics), Application & End User - Global Forecast to 2020

The global electrophoresis technologies market is estimated to reach $1,980.0 Million by 2020, growing at a CAGR of 5% to 6% during the forecast period (2015 to 2020). This market is mainly driven by rising funding for research on electrophoresis techniques, growing number of research collaborations between market players and academic institutions, increasing use of capillary electrophoresis (CE) with mass spectroscopy (MS), and growing focus on next-generation sequencing research. However, alternatives to electrophoresis are available in the market which offer better efficiency and results. In addition, some electrophoresis techniques involve time-consuming operations and offer limited sample analysis, which is restraining the growth of this market to a certain extent during the forecast period.

May 2015 $ 5650 selected

Oxidative Stress Assay Market by Product (Consumables, Instruments, Services), Test Type (Indirect, Enzyme-based, Reactive Oxygen Species (ROS)-based), Technology (ELISA, Chromatography, Flow Cytometry), End Users - Global Forecast to 2020

The global oxidative stress assays market is expected to reach $736.85 Million by 2020 from $452.36 Million in 2015, at a CAGR of 10.25% between 2015 and 2020. Factors such as rapid growth in the biopharmaceutical industry, strong trend of R&D investments in biotechnology and pharmaceutical industries, technological advancements like high-content screening for drug discovery, and government funding for life science research are driving the growth of the oxidative stress assays market. On the other hand, high cost of instruments and dearth of trained manpower for new and emerging technologies are the major factors restraining the growth of this market.

May 2015 $ 5650 selected

Immunoassay Market by Technology (ELISA, Fluorescence, Colorimetric, Chemiluminescence, Rapid Test, Western Blot, ELISPOT, PCR), Application (Infectious Disease, Endocrinology, Cardiology, Oncology, Hematology), & End User - Global Forecast to 2019

Immunoassays have evolved as an integral part of the modern medical care practice owing to the continuous technological advancements in this field, the increase in healthcare awareness among people, and the increasing use of immunoassay tests in diagnosis and monitoring.

May 2015 $ 5650 selected

Genotyping Market by Technology (Polymerase Chain Reaction, Sequencing, Microarray, Electrophoresis, MALDI_TOF), Application (Pharmacogenomics, Diagnostic Research, Animal Genetics, Agricultural Biotechnology) & by Products - Global Forecast to 2020

The global genotyping market is estimated to grow at a CAGR of 22.3% from 2015 to 2020 to reach $17.0 Billion in 2020. Advances in technology, decreasing prices of DNA sequencing, increasing incidence and awareness on genetic diseases & personalized medicine, increasing demand for pharmacogenomics in drug discovery & development, and the increased use of genetic analysis in animal & plant livestock are the major factors driving market growth.

May 2015 $ 5650 selected

Bioburden Testing Market by Product [Instrument (PCR, Microscopes), & Consumables (Kit, Reagent)], Test (Aerobic, Anaerobic, Fungi, Spore), Application (Raw Material, In-process) & End User (Pharmaceutical, Biotechnology, CMO) - Forecast to 2019

The bioburden testing market is expected to reach $565.6 Million by 2019 from $354.4 Million in 2014, at a CAGR of 9.8% from 2014 to 2019. Major factors driving the growth of this market include the growing medical device industry, changing trends in the pharmaceutical and biotechnology industries, increasing food safety concerns to boost the bioburden testing market, strong trend of R&D investments in life sciences, and increasing product recalls due to microbial contamination. However, high cost of instruments and complex and time-consuming regulatory standards which lengthen the approval process in some countries may hinder the growth of this market. Emerging economies such as India and China present an array of opportunities for this market.

May 2015 $ 5650 selected

Cell Counting Market by Product [Instruments (Spectrophotometer, Cell Counter, Hemocytometer, Flow Cytometer, Hematology Analyzer) Consumables (Reagent, Assay Kits, Microplate)], End User (Pharmaceutical, Hospital, Research) - Global Forecast to 2020

The cell counting market is witnessing tremendous growth owing to the growth in the number of cancer patients globally and government participation and support through funding and corporate investments for cell-based research. However, high prices of advanced cell counting instruments and lack of proper healthcare and research infrastructure in emerging markets are hampering the growth of the global cell counting market to a certain extent. The global cell counting market is expected to reach $8.6 Billion by the end of 2020 and is poised to grow at a CAGR of 6.5% to 7.0% during the forecast period (2015 to 2020).

May 2015 $ 5650 selected

Mycoplasma Testing Market by Products (Instruments, Kits & Reagents, Services), Application (Cell Line, Virus, End of Production Cells), Technology (PCR, ELISA, Direct Assay), End User (Cell Banks, Pharmaceutical Companies) - Global Forecast to 2019

The global mycoplasma testing market is expected to reach $613.49 Million by 2019 from $340.29 Million in 2014, growing at a CAGR of 12.51% between 2014 and 2019. Mycoplasma contamination of cell lines and bio therapeutic products represents a significant biosafety concern. The ubiquitous nature of mycoplasma in the environment increases the likelihood of the introduction of these organisms into manufacturing processes. A variety of mycoplasma detection protocols are used in research. Testing is carried out to ensure product quality and safety during different stages of manufacturing process. Mycoplasma testing market refers to a wide range of assays and services aimed at ensuring the quality and purity of products and raw materials used in the production of biologics for the pharmaceutical and biotech industries.

April 2015 $ 5650 selected

Protein Purification & Isolation Market by Technology (Precipitation, Dialysis, Electrophoresis, Western Blotting, Ion Exchange & Affinity Chromatography) by Product (Instruments, Kits, Reagents, Resins) by Application & End User - Global Forecast to 2020

Protein purification is a process for isolation of one or a more proteins from a complex mixture, usually consisting of cells or tissues. Protein purification is a necessary step in any protein study, and is performed after measuring the enzyme activity of the given sample through assay processes to confirm the presence of a protein or proteins of interest. The Global Protein Purification and Isolation Market Is Expected to Reach $11 Billion to $12 Billion by 2020

April 2015 $ 5650 selected

Live Cell Imaging Market by Product (Equipment, Consumables, Software), Technology (Fluorescence Recovery after Photobleaching, High-Content Screening) & by Application (Cell Biology, Stem Cells, Drug Discovery) - Analysis & Global Forecast to 2019

The live cell imaging market is segmented on the basis of products, technologies, applications, and regions. The global live cell imaging market was valued at $3.57 Billion in 2014 and is poised to grow at a CAGR of 8.8% during the forecasted period. Some of the major players in the global live cell imaging market include Carl Zeiss AG (Germany), Leica Microsystems (Germany), Nikon Corporation (Japan), Molecular Devices, LCC (U.S.), PerkinElmer, Inc. (U.S.), GE Healthcare (U.K.), Becton, Dickinson and Company (U.S.), Olympus Corporation (Japan), Sigma Aldrich Corporation (U.S.), and Thermo Fisher Scientific, Inc.(U.S.).

April 2015 $ 5650 selected

Genome Editing / Genome Engineering Market by Application (Cell Line Engineering, Animal & Plant Genetic Engineering), Technology (CRISPR, Antisense, TALEN, Zinc Finger Nuclease) & End User (Biotechnology & Pharmaceutical, CRO) - Global Forecast to 2019

The global genome editing market is expected to reach $3,514.08 Million by 2019 from $1,845.25 Million in 2014, at a CAGR of 13.75% between 2014 and 2019. Factors such as rapid increase in the number of pharmaceutical and biotechnology industries, strong trend of R&D in life science research, increasing government funding for genomics, technological advancements, increased demand for synthetic genes, and the overall rise in the production of genetically modified crops are driving the growth of the genome editing market. On the other hand, stringent regulatory policies and ethical issues are major factors restraining the growth of this market.

April 2015 $ 5650 selected

Biological Safety Testing Market by Application (Stem Cell, Blood, Gene Therapy), Product (Instruments, Services, Kits, Reagents), & Test (Bioburden, Endotoxin, Cell Line Authentication, Residual Contamination, Adventitious Agents) - Global Forecast to 2019

The global biologics safety testing market was valued at $1,758.69 million in 2014 and is poised to grow at a CAGR of 12.23% between 2014 and 2019, to reach $3,130.85 million in 2019. Biologics are products manufactured or extracted from biological sources such as living organisms, and may involve the use of recombinant DNA technology. Over the past five decades, uniform protocols have been developed for safety and toxicity testing of small molecules. On the other hand, biologics have a unique set of properties not usually present in small molecules. As such, the safety testing of biologics is more difficult and requires specialized evaluation.

April 2015 $ 5650 selected

Bioinformatics Market by Sector (Molecular Medicine, Agriculture, Forensic, Animal, Research & Gene Therapy), Segment (Sequencing Platforms, Knowledge Management & Data Analysis) & Application (Genomics, Proteomics & Metabolomics) - Global Forecast to 2020

The growth of the bioinformatics market is driven by increasing government initiatives and funding, and growing use of bioinformatics in drug discovery and biomarkers development processes. It is expected that the market will offer opportunities for bioinformatics solutions manufacturers with the introduction and adoption of upcoming technologies such as nanopore sequencing and cloud computing. The global bioinformatics market accounted for $4.2 billion in 2014 and is poised to reach $13.3 billion by 2020 at a CAGR of 20.9% from 2015 to 2020. The bioinformatics platforms product segment is expected to witness the fastest growth during the forecast period.

April 2015 $ 5650 selected

Molecular Weight Marker Market by Products (DNA, RNA, Protein Ladders), Type (Prestained, Specialty), Application (PCR, Western Blotting, Gel Extraction), & End User (Academic Institutes, Pharmaceutical Companies, CRO) - Global Forecast to 2019

The global molecular weight marker market was valued at $265.36 million in 2014 and is poised to grow at a CAGR of 12.23 % between 2014 and 2019, to reach $472.47 million in 2019. Increased research and development spending by biotechnology and pharmaceutical companies, increasing public funding for life science research, and new innovations in genomics and proteomics research will drive the growth of the molecular weight markers market.

February 2015 $ 5650 selected

Synthetic Biology Market by Tool (XNA, Chassis, Oligos, Enzymes, Cloning kits), Technology (Bioinformatics, Nanotechnology, Gene Synthesis, Cloning & Sequencing), Application (Biofuels, Pharmaceuticals, Biomaterials, Bioremediation) - Global Forecast to 2018

The global synthetic biology market is segmented on the basis of tools, technologies, applications, and regions. Based on tools, the synthetic biology market is categorized into Xeno-nucleic acids, chassis organisms, oligonucleotides, enzymes, and cloning and assembly kits. The global synthetic biology market is expected to reach $5,630.4 million in 2018 from $1,923.1 million in 2013, growing at a CAGR of 24%. The market is dominated byNorth America, followed by Europe, Asia, and Rest of the World (RoW). Europe is expected to dominate the market in terms of the value by 2018.

November 2014 $ 5650 selected

Single Use Bioreactor Market by Product Type (Recombinant Proteins, Monoclonal Antibodies), Cell Type (Bacteria, Yeast), Technology (Stirred SUB, Single Use Bubble Column Bioreactor), End User(Bio pharmaceutical Manufacturers) - Global Forecast to 2019

The single use bioreactors (SUBs) market is expected to grow at a double digit CAGR of 18.4% to reach $470.9 million by 2019 from $202.5 million in 2014. Major factors fueling the growth of this market are low requirements of capital investment for setting up the facility, reduced complexity of automation, and energy efficiency. However, regulatory concerns regarding the mixing process, contamination by leachables and extractable, and difficulties in meeting good manufacturing practices (GMP) standards are restricting the growth of the SUBs market.

October 2014 $ 5650 selected

Protein Characterization and Identification Market by Instruments (Chromatography, Electrophoresis, Mass Spectroscopy), Consumables & Services, Application (Clinical Diagnosis, Drug Discovery & Development), & by End Users - Global Forecast to 2019

The global protein characterization and identification market was valued at $1,569.00 million in 2014, and is expected to grow at a CAGR of 10.63% to reach $2,600.28 million in 2019. Protein characterization and identificationinstruments and consumables find applications in a large number of fields in life science research, as well as clinical diagnosis and drug discovery and development. Protein characterization and identificationproducts are widely used for the biomarker identification applications and characterization of biopharmaceuticals.Being one of the most widely-used applications of protein characterization, drug discovery and development was one of the largest application segments of the global protein characterization and identification market in 2014.

October 2014 $ 5650 selected

Glycobiology/Glycomics Market by Product [Enzymes (Glycosyltransferase, Neuraminidase, Glycosidase), Instruments (HPLC, Mass Spectrometry, MALDI-TOF), Kits, and Reagents], Application (Immunology, Oncology) & by End User - Global Forecast to 2019

The global glycomics market was valued at $512.38 million in 2014, and is expected to grow at a CAGR of 12.62% to reach $928.11 million in 2019. Glycomics enzymes, instruments, kits, & reagentsfind applications in a large number of fields in life science research, as well as diagnostics and drug discovery research. Glycomics products are widely used for the analysis of cell surface markers, which can act as diagnostic or therapeutic targets.Being one of the most widely-used applications of glycomics, drug discovery and development was one of the largest application segments of the global glycomics market in 2014.Glycomics products are often used in the investigation of the role of glycansin the development of cancer, Alzheimer’s, Parkinson’s, and infectious diseases like herpes and AIDS.

September 2014 $ 5650 selected

RNA Analysis/Transcriptomics Market by Technology (Microarray, PCR, NGS, RNAi), by Application (Clinical Diagnostics, Drug Discovery, Toxicogenomics), by End-User (Academic Research, Pharmaceutical and Biotech Companies) - Global Forecast to 2019

The global transcriptomics market was valued at $1,743.2 million in 2013 and is expected to reach at $3,773.0 million by 2019, at a CAGR of 13.7% during the forecast period of 2014 to 2019. This market is mainly driven by the increasingtechnological advancements, increasing investment in research and development by biotechnology and pharmaceutical companies, rising government and private funding, and growing preference for personalized medicines. However, lack of skilled professionals in the transcriptomics field and lack of efficient bioinformatics and data analysis tools to analyze enormous data generated from the high-throughput sequencing technologies expected to restrain the growth of this market to a certain extent

September 2014 $ 5650 selected

Cell Line Development Market by Product (Equipment, Media and Reagents), Source, type & by Application ( Bioproduction, Tissue Engineering & Regenerative medicine, Toxicity Testing, Research, Drug Discovery) - Analysis & Global Forecast to 2019

The global cell line development market is expected to reach 3.96 billion by 2019 from $2.2 billion in 2014, and is expected to grow at a CAGR of 12.5% from 2014 to 2019. The market is dominated by North America, followed by Europe, Asia, and Rest of the World (RoW). North America is expected to maintain its leadership position in the market in the coming years.

September 2014 $ 5650 selected

Chiral Chromatography Column Market by type (Empty, Pre-packed, Analytical, Preparative), Material (Metal, Glass, Plastic), & by Application [GC, LC (HPLC, UHPLC, Flash Chromatoraphy, UFLC), TLC,SFC] - Forecast to 2018

The chiral chromatography column market is segmented on the basis of columns, materials, applications, end users, and geography.The chiral chromatography columnsmarket comprisesof two types of columns empty and pre-packed columns. The pre-packed columns are further categorized into analytical columns and preparative columns. The chiral chromatographycolumnsmarket size was $68 million in 2013 and is expected to reach $87.8 million by 2018, at a CAGR of 5.2%.

September 2014 $ 5650 selected

Companion Diagnostics Market byTechnology (Polymerase Chain Reaction, In-situ hybridization, Immunohistochemistry), Application (Breast, Lung cancer), & by End-user (Pharmaceutical Companies, Reference Lab)] - Global Trends & Forecasts to 2019

The global companion diagnostic market is expected to reach $8,730.7 million by 2019 from $3,136.9 million in 2014, growing at a CAGR of 22.7%. The growth of this market can be attributed to the growing demand of targeted drugs in oncology, neurology, and infectious diseases and the support from regulatory authorities across the globe.

September 2014 $ 5650 selected

Whole Exome Sequencing Market by Product [Systems, Kits (Library Preparation, Target Enrichment)], Services (Sequencing), Technology (Sequencing by Synthesis), & by Application (Cancer, Monogenic disorders) - Global Forecast to 2018

This global whole exome sequencing market was valued at $326.6 million in 2013 and is expected to grow at a CAGR of 22.0% from 2013 to 2018, to reach $884.1 million by 2018. The market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). North America is expected to maintain its leadership in the market in the coming years. Growth in the North American market is likely to be driven by factors such as the increasing use of exome sequencing in rare disease research, increased government funding, and large number of sequencing-related conferences and annual meetings hosted by the U.S.

August 2014 $ 5650 selected

Western Blotting Market by Product (Instruments (Manual/Semi-automated/Automated), Consumables (Kits/Reagents/Membrane), by Application (Disease Diagnosis/Agriculture/Biomedical Research) - End-User Analysis & Global Forecast to 2018

The global western blotting market was valued at $296 million in 2013 and is expected to grow at a CAGR of 4.8% from 2013 to 2018, to reach $374.2 million by 2018. The market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). North America is expected to maintain its leadership position in the market in the coming years.

August 2014 $ 5650 selected

Microbial Identification Market by Products (Consumables, Instruments, Services), Methods (Phenotypic, Genotypic), Application (Pharmaceutical, Diagnostic, Environmental, Food & Beverages) & by End User (Detection, Characterization) - Global Forecasts to 2019

The global microbial identification market is valued at an estimated $896.5 million by the end of 2014 and is expected to reach $1,194.1 million by 2019, growing at a CAGR of 5.9% from 2014 to 2019. The microbial identification market is segmented on the basis of products, methods, applications, end users, and geographies.

July 2014 $ 5650 selected

Metabolomics Market by Technique (Gas Chromatography, High Performance Liquid Chromatography, Nuclear Magnetic Resonance Spectroscopy, Mass Spectrometry), Application (Biomarker & Drug Discovery, Nutrigenomics) & by Indication (Oncology, Cardiology) - Global Forecast to 2019

Over the last decade, there has been a tremendous development in biochemistry and molecular biology which has had a positive impact on the overall growth of the metabolomics market. The market has witnessed the introduction of many advanced analytical equipment and data processing programs.

June 2014 $ 5650 selected

Isothermal Nucleic Acid Amplification Technology (INAAT) Market by Application (Infectious Diseases, Blood Screening, Research), Products (Instruments, Reagents), End-User (Hospital, Reference Laboratories, Other) - Global Forecast to 2018

The global isothermal nucleic acid technology (INAAT) market is estimated to reach $1,651 million by 2018 at a CAGR of 13.5% during the forecast period. The market growth is primarily attributed to increasing demand for advanced isothermal based molecular testing over conventional thermal polymerase chain reaction (PCR) technology.

May 2014 $ 5650 selected

Human Identification Market by Technology (Next Generation Sequencing, Rapid DNA Analysis, Capillary Electrophoresis, PCR), Application (Forensics, Paternity Testing), DNA Amplification, Quantification, Extraction, Services, & Software - Forecast to 2018

The global human identification market was valued at an estimated $419.4 million in 2013 and is expected to grow at a CAGR of 13.9% in the next five years. This high growth is mainly attributed to the rising need to reduce time and cost of DNA analysis, government support in the form of funding, rapid technological advancements, and conferences and symposiums related to usage of new technologies in DNA profiling.

May 2014 $ 5650 selected

Protein Expression Market by Products (Expression Vector, Service, Reagent), Application (Industrial, Therapeutic), Expression Systems (Mammalian, Prokaryotic, Baculovirus, Yeast) & by End User (Pharmaceutical, Biotechnology, CRO) - Global Forecast to 2018

Protein expression is an essential component of proteomics that plays an important role in research by allowing the expression of genetically engineered recombinant proteins in various host cells. The protein expression market includes reagents, expression vectors, and competent cells used for transfection and maintenance of competent cells. As a result of the declining R&D rate of productivity and the sales drop expected by the upcoming patent cliff, the growing research intensity in the pharmaceutical sector will be an important growth driver for this market during the forecast period between 2013 and 2018. In addition, the development in the biologics and proteomics market will boost the research in protein expression, thus being a vital growth driver.

April 2014 $ 5650 selected

Proteomics Market by Technology (Protein Microarray, Mass Spectrometry, NMR Spectroscopy, Chromatography, Electrophoresis, Surface Plasmon Resonance, X-ray Crystallography) - Instruments, Reagents & Services - Global Forecast to 2018

The proteomics market showcases a high growth potential, owing to the growing awareness about personalized medicine and the resultant increase in the use of proteomic technologies-based advancement in the pharmaceutical industry.

March 2014 $ 5650 selected

Pharmaceutical Membrane Filtration Market by Technology (Microfiltration, Ultra filtration, Nanofiltration, Reverse Osmosis & Ion Exchange), Application (Cell Separation, Protein Purification, Sterilization, Virus Removal & Water Management), Region (North America, Europe, Asia-Pacific & ROW) - Trends & Forecast to 2018

The global pharmaceutical membrane filtration market is segmented on the basis of technology, application, and region. The technology segments included in the report are microfiltration, ultrafiltration, nanofiltration, reverse osmosis, and ion exchange; the application segments are cell separation, protein purification, sterilization, virus removal, and water management; while the geographic segments are North America, Europe, Asia-Pacific, and Rest of the World (RoW).

March 2014 $ 5650 selected

Protein Crystallization & Crystallography Market by Technology (Ion-Exchange Chromatography, HPLC, Gel-Electrophoresis, NMR, X-Ray Crystallography), Products (Reagents & Instruments) & End-Users (Pharmaceutical & Biotechnology Companies) - Forecast to 2018

The future growth prospects for the protein crystallization & crystallography market are optimistic and it is estimated to grow at a CAGR of 10.1% to reach a worldwide market of $1,253 million by 2018. The increasing use of crystallization for membrane protein structure elucidation, increasing R&D by big pharmaceutical and biotechnology firms, technological advancements, and increasing government funding are all factors that are expected to fuel the growth of the protein crystallization & crystallography market in the near future. However, insufficiency of qualified and experienced researchers, lack of generalized crystallization methods associated with the types of proteins, and highly time-consuming and expensive protein crystallization and crystallography processes are expected to hinder the growth of this market during the forecasted period. The key unmet market needs provide huge opportunities for both, the key players and new entrants in this industry.

February 2014 $ 5650 selected

High Content Screening Market by Instruments (Cell Imaging and Analysis System), by Applications (Primary and Secondary Screening, Target Identification and Validation, Toxicity Studies, Compound Profiling), Software & Services - Global Forecasts to 2018

The global high content screening market is segmented on the basis of products, applications, end users, and geography. The products market is further segmented into instruments, consumables, software, and services. Based on applications, the high content screening market is divided into primary and secondary screening, target identification and validation, toxicity studies, compound profiling, and other applications. Based on end users, the high content screening market is segmented into pharmaceutical and biotechnology companies, academic and government institutes, and contract research organizations (CROs). Based on geography, this market is divided into North America, Europe, Asia, and the Rest of the World (RoW).

February 2014 $ 5650 selected

High Throughput Screening (HTS) Market by Technology (Cell Based, Ultra High Throughput Screening (UHTS), Label Free, Bioinformatics), by Applications (Target Identification, Primary Screening, Toxicology, Stem Cell) & by End Users (Pharmaceutical Industry, Biotechnology Industry, CRO) - Forecast to 2018

The global HTS market was valued at $13.7 billion in 2013 and is expected to grow at a CAGR of 7.4% over the next five years. A number of factors such as technological innovations, increasing adoption of open innovation models by pharmaceutical companies, increasing drug discovery initiatives by academic institutions, and huge capital investments in HTS technology by organizations are driving the growth of this market. The HTS market is segmented on the basis of technology, products, applications, end users, and geography. The global HCS market report studies the market estimations and trends for the above mentioned segments in four geographies, namely, North America, Europe, Asia, and RoW (Rest of the World). The growth in outsourcing of drug discovery services, especially in China and India, and the presence of a large untapped market in emerging countries are the factors that are expected to present growth opportunities to players in the HTS market. However, factors such as the capital intensive nature of HTS and difficulties in assay development for novel target classes are hampering the growth of this market.

February 2014 $ 5650 selected

Cancer/Tumor Profiling Market [Applications (Personalized Medicine, Diagnostics, Biomarker Discovery, Prognosis, Research), Technologies (NGS, QPCR, IHC, FISH/CISH, Microarray), Segments: Genomics, Proteomics, Metabolomics, Epigenetics)] 2013 - 2018

Cancer/Tumor profiling is a promising market and is witnessing significant growth in the healthcare industry. It is poised to grow rapidly in a range of application areas, including biomarker discovery and prognosis. The global cancer/tumor profiling market is valued at $14.99 billion in 2013 and is expected to reach $35.03 billion by 2018.

September 2013 $ 5650 selected

Vital Signs Monitoring Market - Landscape Analysis of Blood Pressure Monitoring Devices, Pulse Oximeters and Temperature Monitoring Devices - Forecasts up to 2018

The word “vital” connotes the most significant requirement for sustaining healthy life. Blood pressure, respiratory rate, heart rate and body temperature within a normal range are necessary for the survival of human life and these parameters are referred to as vital signs.

August 2013 $ 5650 selected

European Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free injectors, Auto-injectors, Nasal sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Forecasts to 2017

The Europeandrug delivery market was worth $39.9 billion in the year 2012. The drug delivery technology market is segmented on the basis of route of administration into nine categories - oral, pulmonary, transdermal, injectable, ocular, nasal, topical, implantable, and transmucosal drug delivery.

June 2013 $ 5650 selected

North America Injectable Drug Delivery Market – by Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables & Reusable, Fillable & Prefilled, Pen, Needle Free & Auto Injectors] & Therapeutics [Diabetes & Oncology] – Forecasts to 2017

The North American injectable drug delivery technologies market was valued at $9.3 billion in 2012; it is expected to reach $16.6 billion by 2017 at a CAGR of 12.3% from 2012 to 2017. Injectable drug delivery technologies are the combination of two major segments; devices and formulations. The North American injectable drug delivery formulations technologies market was the largest segment in this market. In addition, the market is segmented on the basis of its therapeutic applications. In therapeutic area, hormonal disorders command the major segment of injectable drug delivery technologies market due to high demand of injectable in treatment of diabetes. However, auto-immune diseases are the fastest growing segment of this market due to the advent of biologics (tumor necrosis factor (TNF) and Interleukin 1 (IL-1)) and improving patient compliance by the development of self injection devices.

April 2013 $ 5650 selected

Global Transfection Technologies Market (Lipofection, Calcium Phosphate, Electroporation, Nucleofection, Magnetofection, Gene Gun, Viral) And Types (Gene Delivery, DNA Delivery, Protein Delivery, SiRNA Delivery) (2012 – 2017)

Transfection is an enabler technology used for many cell based research activities with applications spanning production of recombinant proteins and recombinant cell lines, gene therapy, delivery of therapeutics and also drug discovery. This research report provides a brief description on transfection technologies, its evolution, comparative analysis, market landscape analysis, competitive scenario and emerging technology and application trends.

December 2012 $ 5650 selected

Biotechnology Reagents Market by Technology (PCR, Cell Culture, Expression & Transfection, Chromatography, Mass Spectrometry, Electrophoresis, & Flow Cytometry), Applications (Protein Purification, Gene Expression, DNA & RNA Analysis, & Drug Testing) and End-Users - Current Trends, Opportunities and Global Forecasts to 2016

Biotechnology reagents are the substances or compounds used to detect or synthesize another substance in order to provide a test reading. These reagents are used in the field of research, diagnosis, bioscience, and education.

July 2012 $ 5650 selected

Life Sciences & Analytical Reagents Market - Applications, Current Trends, Opportunities & Global Forecasts (2011 – 2016)

The life sciences and analytical reagents market report studies the life science and analytical reagents market, by technology, end-users, and applications. The life sciences and analytical reagents market, by technology studied in this report are segmented as life science reagents and analytical reagents; of which life science segment accounted for the largest share of 59.37% of the total market in 2011.

May 2012 $ 5650 selected

Global DNA and Gene Chip (Microarrays) Market (2010 – 2015)

The Global DNA & Gene Chip (microarray) market was valued at $760 million in 2010 and is expected to reach $1,425.2 million by 2015 growing at a CAGR of and 13.4%. The oDNA segment accounted for the largest share – 98% – of the global DNA & gene chip market in 2010.

May 2011 $ 5650 selected

Brazil Biomaterials Market (2010-2015)

Brazil Biomaterials Market is expected to reach $1.7 billion in 2015 from $550.2 million in 2008 with a CAGR of 19.5% from 2010 to 2015. In 2009, the orthopedic biomaterial market recorded revenues of $236.5 million or 37.5% of the total biomaterial products market. This is mainly because of increasing application areas and introduction of sophisticated technologies in the biomaterials market. However, the orthopedic biomaterial market is estimated to grow at a CAGR of 17.2% from 2010 to 2015. Cardiovascular biomaterial products market is the second-highest market, contributing 36% of the total biomaterial products market.

May 2011 $ 5650 selected

Top 10 Drug Delivery Technologies Market (Topical, Oral Time Release/Sustained Release, Targeted Delivery, Encapsulation, Aerosol/Inhalation, Transdermal, Implants, Injectable, Liposomal, Pegylation) - Global Trends, Challenges & Forecasts up till 2015

This report provides industry analysis, competitive landscape and in-depth market segmentation for all the top 10 drug delivery technologies. It provides market data for the oral delivery system, which still dominates the drug delivery market. In addition, the report also analyzes the market data on emerging drug delivery technologies like needleless injectables, PEGylation technologies and microelectromechanical devices.

February 2011 $ 5650 selected

Strategic Analysis & Forecast of US Biopharmaceutical Industry (2009-2016): Impact of Healthcare Reform, Technological Innovation & Market

The U.S. biopharmaceuticals market is expected to increase to $144 billion by 2016. The growth is expected as a result of the launch of new products, approval of new indications for existing therapies and drugs, and increase in population aged 65 years and above. From 2009 to 2016 the U.S. market revenues are forecasted to grow at a compound annual growth rate (CAGR) of 11.2%.

February 2011 $ 5650 selected

Top 10 Drug Discovery Technologies Market – Strategic Analysis and Global Forecasts (2010 to 2015)

The top 10 drug discovery technologies play a vital role in the growth of the entire pharmaceutical industry as they are the key contributors in the swift introduction of blockbusters and innovative drugs, which is the most important aspect for the pharmaceutical companies.

November 2010 $ 5650 selected



Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us


Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 

Live Chat Support



US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



M&M Custom Research Services provides clients with the information on their business scenario required to stay ahead of competition in today's fast paced business environment.
'Connect With Us

Call us at: 1-888-600-6441
Live Chat Support


Access reports on all high
growth Biotechnology Markets on KnowledgeStore
Request Demo